News

Forbes: In Big Shift, 23andMe Will Invent Drugs Using Customer Data

March 12, 2015

Forbes: In Big Shift, 23andMe Will Invent Drugs Using Customer Data

Matthew Herper

23andMe, the Google backed personal genetics startup, will no longer just sell tests to consumers, or genetic data to pharmaceutical companies. This morning, it announced that it plans to start inventing medicines itself.

It’s not just talk. The company has hired Richard Scheller, who led drug discovery at biotech icon Genentech for 14 years before announcing he would retire in December, and who has won some of science’s top awards, including the Lasker Prize, often referred to as “America’s Nobel,” and the Kavli Prize.

Read Full Article